Interferon does not improve outcomes for hospitalized adults with COVID-19, clinical trial finds — …

A clinical trial has found that treatment with the immunomodulator interferon beta-1a plus the antiviral remdesivir was not superior to treatment with remdesivir alone in hospitalized adults with COVID-19 pneumonia. In addition, in a subgroup of patients who required high-flow oxygen,…

Click here to view the original article.